- Report
- May 2024
- 128 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Lamictal is an anticonvulsant drug used to treat mental disorders such as bipolar disorder, major depressive disorder, and schizophrenia. It is also used to treat epilepsy and other seizure disorders. Lamictal is a brand name for the generic drug lamotrigine, which is manufactured by GlaxoSmithKline. Lamictal is available in both immediate-release and extended-release formulations. The drug is generally well-tolerated and has few side effects.
The Lamictal market is highly competitive, with several major pharmaceutical companies competing for market share. Companies such as Pfizer, Novartis, and Johnson & Johnson are all major players in the mental disorders drugs market. Other companies such as Mylan, Teva, and Sun Pharmaceuticals also have a presence in the market. Show Less Read more